Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Nuclear Proteome of White and Gray Matter from Schizophrenia Postmortem Brains
Verônica M. Saia‐Cereda, Aline G. Santana, Andrea Schmitt, et al.
Complex Psychiatry (2017) Vol. 3, Iss. 1, pp. 37-52
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Mapping gray and white matter volume abnormalities in early-onset psychosis: an ENIGMA multicenter voxel-based morphometry study
Shuqing Si, Anbreen Bi, Zhaoying Yu, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 2, pp. 496-504
Open Access | Times Cited: 12
Implications of Newly Identified Brain eQTL Genes and Their Interactors in Schizophrenia
Lei Cai, Tao Huang, Jingjing Su, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 12, pp. 433-442
Open Access | Times Cited: 72
Assessing Cognitive Impairment in Patients With Schizophrenia
S. Charles Schulz, Aimee Murray
The Journal of Clinical Psychiatry (2016) Vol. 77, Iss. Suppl 2, pp. 3-7
Closed Access | Times Cited: 33
<b><i>VRK2</i></b>, a Candidate Gene for Psychiatric and Neurological Disorders
Ming Li, Weihua Yue
Complex Psychiatry (2018) Vol. 4, Iss. 3, pp. 119-133
Open Access | Times Cited: 33
Transcriptional Regulators in the Cerebellum in Chronic Schizophrenia: Novel Possible Targets for Pharmacological Interventions
América Vera-Montecinos, Belén Ramos
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3653-3653
Open Access
Quantitative Subcellular Proteomics of the Orbitofrontal Cortex of Schizophrenia Patients
Erika Velásquez, Daniel Martins‐de‐Souza, Ingrid Velásquez, et al.
Journal of Proteome Research (2019) Vol. 18, Iss. 12, pp. 4240-4253
Closed Access | Times Cited: 26
Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients' postmortem brains
Juliana Nascimento, Verônica M. Saia‐Cereda, Giuliana S. Zuccoli, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Digging deeper in the proteome of different regions from schizophrenia brains
Guilherme Reis‐de‐Oliveira, Giuliana S. Zuccoli, Mariana Fioramonte, et al.
Journal of Proteomics (2020) Vol. 223, pp. 103814-103814
Closed Access | Times Cited: 22
The Roles of hnRNP Family in the Brain and Brain-Related Disorders
Caroline Brandão‐Teles, André Saraiva Leão Marcelo Antunes, Talita Aparecida de Moraes Vrechi, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 6, pp. 3578-3595
Closed Access | Times Cited: 8
Calcium-binding proteins are altered in the cerebellum in schizophrenia
Francisco Vidal-Domènech, Gemma Riquelme Alacid, Raquel Pinacho, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0230400-e0230400
Open Access | Times Cited: 18
The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia
Karin E. Borgmann‐Winter, Kai Wang, Sabyasachi Bandyopadhyay, et al.
Schizophrenia Research (2019) Vol. 217, pp. 148-161
Open Access | Times Cited: 17
Mass spectrometry methods for analysis of extracellular matrix components in neurological diseases
Margaret Downs, Joseph Zaia, Manveen K. Sethi
Mass Spectrometry Reviews (2022) Vol. 42, Iss. 5, pp. 1848-1875
Closed Access | Times Cited: 10
Biochemical Pathways Triggered by Antipsychotics in Human Oligodendrocytes: Potential of Discovering New Treatment Targets
Caroline Brandão‐Teles, Valéria de Almeida, Juliana S. Cassoli, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 14
An overview of the human brain myelin proteome and differences associated with schizophrenia
Daniel Martins‐de‐Souza, Paul C. Guest, Guilherme Reis‐de‐Oliveira, et al.
The World Journal of Biological Psychiatry (2020) Vol. 22, Iss. 4, pp. 271-287
Closed Access | Times Cited: 14
Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients
Sheila Garcia, Benilton S. Carvalho, Paul C. Guest, et al.
Journal of Proteomics (2020) Vol. 224, pp. 103813-103813
Closed Access | Times Cited: 11
The Human Brain Proteome Project: Biological and Technological Challenges
Joaquín Fernández‐Irigoyen, Fernando J. Corrales, Enrique Santamaría
Methods in molecular biology (2019), pp. 3-23
Closed Access | Times Cited: 7
A bioinformatic inquiry of the EAAT2 interactome in postmortem and neuropsychiatric datasets
Sophie M. Asah, Khaled Alganem, Robert E. McCullumsmith, et al.
Schizophrenia Research (2020) Vol. 249, pp. 38-46
Open Access | Times Cited: 6
14-3-3 proteins at the crossroads of neurodevelopment and schizophrenia
André Saraiva Leão Marcelo Antunes, Verônica M. Saia‐Cereda, Fernanda Crunfli, et al.
The World Journal of Biological Psychiatry (2021) Vol. 23, Iss. 1, pp. 14-32
Closed Access | Times Cited: 5
Calcium-Binding Proteins are Altered in the Cerebellum in Schizophrenia
Francisco Vidal-Domènech, Gemma Riquelme Alacid, Raquel Pinacho, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4
Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders
André Saraiva Leão Marcelo Antunes, Valéria de Almeida, Fernanda Crunfli, et al.
Advances in experimental medicine and biology (2021), pp. 251-264
Closed Access | Times Cited: 4
What Can We Learn from Animal Models to Study Schizophrenia?
Fernanda Crunfli, Caroline Brandão‐Teles, Giuliana S. Zuccoli, et al.
Advances in experimental medicine and biology (2022), pp. 15-33
Closed Access | Times Cited: 2
Proteomic Mapping of the Human Myelin Proteome
Paul C. Guest
Methods in molecular biology (2021), pp. 191-202
Closed Access | Times Cited: 2
Proteomics and Schizophrenia: The Evolution of a Great Partnership
Bradley J. Smith, Victor Corasolla Carregari, Daniel Martins‐de‐Souza
Advances in experimental medicine and biology (2022), pp. 129-138
Closed Access | Times Cited: 1
Modeling Schizophrenia In Vitro: Challenges and Insights on Studying Brain Cells
Caroline Brandão‐Teles, Giuliana S. Zuccoli, Bradley J. Smith, et al.
Advances in experimental medicine and biology (2022), pp. 35-51
Closed Access | Times Cited: 1
Postmortem Brains: What Can Proteomics Tell us About the Sources of Schizophrenia?
Guilherme Reis‐de‐Oliveira, Bradley J. Smith, Daniel Martins‐de‐Souza
Advances in experimental medicine and biology (2022), pp. 1-13
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top